These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30460526)

  • 1. Precision medicine in renal stone-formers.
    Hill F; Sayer JA
    Urolithiasis; 2019 Feb; 47(1):99-105. PubMed ID: 30460526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirical therapy or precision medicine for kidney stone formers in the '-omics' era?
    Gambaro G
    Urolithiasis; 2019 Feb; 47(1):1-3. PubMed ID: 30498937
    [No Abstract]   [Full Text] [Related]  

  • 3. Personalized Intervention in Monogenic Stone Formers.
    Policastro LJ; Saggi SJ; Goldfarb DS; Weiss JP
    J Urol; 2018 Mar; 199(3):623-632. PubMed ID: 29061541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urine analyses for workup of kidney stone disease--interpretation and therapeutic consequences].
    Pasch A
    Ther Umsch; 2006 Sep; 63(9):569-74. PubMed ID: 17048170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Evolving Role of Genetic Testing in Monogenic Kidney Stone Disease: Spotlight on Primary Hyperoxaluria.
    Breeggemann MC; Harris PC; Lieske JC; Tasian GE; Wood KD
    J Urol; 2024 Nov; 212(5):649-659. PubMed ID: 39093847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric therapy for kidney stones.
    Goldfarb DS
    Urolithiasis; 2019 Feb; 47(1):107-113. PubMed ID: 30478476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association Between 24-Hour Urine and Stone Recurrence Among High Risk Kidney Stone Formers: A Population Level Assessment.
    Samson PC; Holt SK; Hsi RS; Sorensen MD; Harper JD
    Urology; 2020 Oct; 144():71-76. PubMed ID: 32540303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of kidney stone disease.
    Howles SA; Thakker RV
    Nat Rev Urol; 2020 Jul; 17(7):407-421. PubMed ID: 32533118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the heritability of idiopathic nephrolithiasis.
    Griffin DG
    J Clin Pathol; 2004 Aug; 57(8):793-6. PubMed ID: 15280397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic assessment of monogenic etiology in adult-onset kidney stone formers undergoing urological intervention-evidence for genetic pretest probability.
    Schönauer R; Scherer L; Nemitz-Kliemchen M; Hagemann T; Hantmann E; Seidel A; Müller L; Kehr S; Voigt C; Stolzenburg JU; Halbritter J
    Am J Med Genet C Semin Med Genet; 2022 Sep; 190(3):279-288. PubMed ID: 35923129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic predisposition to renal stone disease in the first-degree relatives of stone-formers.
    Marya RK; Dadoo RC; Sharma NK
    Urol Int; 1981; 36(4):245-7. PubMed ID: 7331055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic evaluation and medical therapy for stone formation.
    Krautschick AW
    Curr Opin Urol; 1999 Jul; 9(4):335-8. PubMed ID: 10459471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How the diagnosis and the management of genetic renal phosphate leak impact the life of kidney stone formers?
    Tostivint IN; Araman RG; Castiglione V; Alkouri R; Vargas-Poussou R; Conort P; Inaoui R; Dousseaux MP; Merazga S; Lalmi Z; Chaoui I; Pieroni L; Deray G; Isnard-Bagnis C; Izzedine H
    Urolithiasis; 2022 Jun; 50(3):319-331. PubMed ID: 35224662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary style and acid load in an Italian population of calcium kidney stone formers.
    Vezzoli G; Dogliotti E; Terranegra A; Arcidiacono T; Macrina L; Tavecchia M; Pivari F; Mingione A; Brasacchio C; Nouvenne A; Meschi T; Cusi D; Spotti D; Montanari E; Soldati L
    Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):588-93. PubMed ID: 25921845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis and urolithiasis.
    Caudarella R; Vescini F; Buffa A; La Manna G; Stefoni S
    Urol Int; 2004; 72 Suppl 1():17-9. PubMed ID: 15133327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperoxaluria in idiopathic calcium nephrolithiasis--what are the limits?
    Osther PJ
    Scand J Urol Nephrol; 1999 Dec; 33(6):368-71. PubMed ID: 10636575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal stone disease.
    Sayer JA
    Nephron Physiol; 2011; 118(1):p35-44. PubMed ID: 21071986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of urinary calcium excretion after oral calcium load in stone formers, their spouses and first-degree blood relatives.
    Kaul P; Sidhu H; Vaidyanathan S; Thind SK; Nath R
    Urol Int; 1994; 52(2):93-7. PubMed ID: 8178384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of renal phosphate leak among patients with calcium nephrolithiasis.
    Prié D; Ravery V; Boccon-Gibod L; Friedlander G
    Kidney Int; 2001 Jul; 60(1):272-6. PubMed ID: 11422761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inherited monogenic kidney stone diseases: recent diagnostic and therapeutic advances].
    Jungers P; Joly D; Blanchard A; Courbebaisse M; Knebelmann B; Daudon M
    Nephrol Ther; 2008 Jul; 4(4):231-55. PubMed ID: 18499551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.